Skip to main content
HairCited

Chemotherapy-Induced Hair Loss
Chemotherapy-Induced Hair Loss

Prävalenz: Affects 65-85% of chemotherapy patients depending on regimen

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'condition\u003Dchemotherapy\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    






    
    

        
        

        
        
        

            

  
About





            

                
Rapid, diffuse hair loss (anagen effluvium) caused by cytotoxic chemotherapy agents that target rapidly dividing cells, including hair matrix keratinocytes. Hair typically regrows after treatment completion, though texture and color may change.

            

        

        

        
        
        

            

  
Common Symptoms





            

                
                Rapid diffuse shedding
                
                Complete scalp hair loss
                
                Eyebrow and eyelash loss
                
                Body hair loss
                
            

        

        

        
        
        

            

  
Risk Factors





            
    
                
                
  • 
                    
                    Taxane chemotherapy
                
    • 
                
                
  • 
                    
                    Anthracycline chemotherapy
                
    • 
                
                
  • 
                    
                    Combination regimens
                
    • 
                
                
  • 
                    
                    Higher doses
                
    • 
                
            

        

        

        
        
        

            

  
Frequently Asked Questions





            

                
                

                    
                        How is the evidence for Chemotherapy-Induced Hair Loss supplements graded?
                        
                    
                    

                        We grade supplements on an A-F scale based on clinical study quality, consistency of results, sample sizes, and study design. Grade A indicates strong evidence from multiple clinical trials, while Grade D indicates preliminary evidence requiring further research.
                    

                

                
                

                    
                        What are common symptoms of Chemotherapy-Induced Hair Loss?
                        
                    
                    

                        Common symptoms associated with Chemotherapy-Induced Hair Loss include Rapid diffuse shedding, Complete scalp hair loss, Eyebrow and eyelash loss, Body hair loss. If you are experiencing these symptoms, consult a healthcare professional for proper diagnosis and treatment options.
                    

                

                
            

        

        

        
        
    


    
    












    

        FDA-Haftungsausschluss:
        Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.